@ Southeast BIO

"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

ImmunArray gets $10 million investment

RICHMOND, VA. – ImmunArray, a company based in the Virginia Biotechnology Research Park in Richmond, has received a $10 million investment that will help it further develop its blood-testing technology for chronic diseases such as lupus and for traumatic head injuries.

read more

3 Months until #SEBIO2016!!

Early Bird Registration is open until July 29th!!  Save $100 by registering now!

The flow of the meeting is different this year, so check out the agenda to see how things are coming along.

Looking forward to seeing everyone there!

read more

Arbor Pharmaceuticals to Acquire XenoPort

Arbor Pharmaceuticals, LLC and XenoPort, Inc. announced today that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.03 per share in cash, or a total equity value of approximately $467 million.

read more